Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Heart failure: a central factor in progressive mechanical and electrical cardiac dysfunction.

Moss AJ.

Ann Noninvasive Electrocardiol. 2005 Jul;10(3):279-80. No abstract available.

PMID:
16029377
2.

Heart failure.

McKelvie R.

Clin Evid. 2006 Jun;(15):118-39. Review. No abstract available.

PMID:
16973007
3.

[Tachycardia-induced cardiomyopathy].

Komamura K.

Nihon Rinsho. 2007 May 28;65 Suppl 5:439-45. Review. Japanese. No abstract available.

PMID:
17571416
4.

Electrophysiological interventions for treatment of congestive heart failure in pediatrics and congenital heart disease.

Dubin AM, Berul CI.

Expert Rev Cardiovasc Ther. 2007 Jan;5(1):111-8. Review.

PMID:
17187462
5.

[Chronic heart failure treatment in the year 2006].

De Berrazueta Fernández JR.

An R Acad Nac Med (Madr). 2006;123(3):617-30. Review. Spanish.

PMID:
17451101
6.

The cardiomyopathies.

Goodwin JF, Oakley CM.

Br Heart J. 1972 Jun;34(6):545-52. Review. No abstract available.

7.

[Cardiac sarcoidosis associated with heart failure].

Otsuka K, Terasaki F, Kitaura Y.

Nihon Rinsho. 2007 May 28;65 Suppl 5:446-50. Review. Japanese. No abstract available.

PMID:
17569323
8.

Cardiac resynchronisation therapy for heart failure.

Mariani JA, Gould PA, Broughton A, Kaye DM.

Intern Med J. 2006 Feb;36(2):114-23. Review.

PMID:
16472265
9.

New concepts in hypertrophic cardiomyopathies, part II.

Roberts R, Sigwart U.

Circulation. 2001 Oct 30;104(18):2249-52. Review. No abstract available.

10.

A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.

Tung R, Zimetbaum P, Josephson ME.

J Am Coll Cardiol. 2008 Sep 30;52(14):1111-21. doi: 10.1016/j.jacc.2008.05.058. Review.

11.

The year in heart failure.

Tang WH, Francis GS.

J Am Coll Cardiol. 2010 Feb 16;55(7):688-96. doi: 10.1016/j.jacc.2009.10.028. Review. No abstract available.

13.

Peripartum cardiomyopathy.

Murali S, Baldisseri MR.

Crit Care Med. 2005 Oct;33(10 Suppl):S340-6. Review.

PMID:
16215357
14.

Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?

Turley AJ, Raja SG, Salhiyyah K, Nagarajan K.

Interact Cardiovasc Thorac Surg. 2008 Dec;7(6):1141-6. doi: 10.1510/icvts.2008.183707. Epub 2008 Jun 9. Review.

PMID:
18541605
15.

Therapeutic options in advanced heart failure.

Fisher ML, Balke CW, Freudenberger R.

Hosp Pract (1995). 1997 Dec 15;32(12):97-106. Review.

PMID:
12828362
16.

New insights into cardiac resynchronization therapy.

Epstein AE.

Clin Cardiol. 2005 Nov;28(11 Suppl 1):I45-50. Review.

17.

Rhythm management in pediatric heart failure.

Berul CI, Dubin AM.

Congenit Heart Dis. 2006 Jul;1(4):140-7. doi: 10.1111/j.1747-0803.2006.00025.x. Review.

PMID:
18377538
18.

Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.

Mishkin JD, Saxonhouse SJ, Woo GW, Burkart TA, Miles WM, Conti JB, Schofield RS, Sears SF, Aranda JM Jr.

J Am Coll Cardiol. 2009 Nov 24;54(22):1993-2000. doi: 10.1016/j.jacc.2009.07.039. Review.

19.

Sudden death prevention with implantable devices.

Passman R, Kadish A.

Circulation. 2007 Jul 31;116(5):561-71. Review. No abstract available.

20.

Managing heart failure better: the value of implantable device data.

Best JF, Feldker H, Aggarwal K, Tejwani L.

Mo Med. 2008 Sep-Oct;105(5):441-6. Review. Erratum in: Mo Med. 2008 Nov-Dec;105(6):536.

PMID:
18807369

Supplemental Content

Support Center